Literature DB >> 1085776

Hemophilus influenzae, type b, antibody frequencies determined with bactericidal and radioimmunoassay tests.

C W Norden, H A Feldman.   

Abstract

Bactericidal and radioimmunoassay (RIA) antibodies to Hemophilus influenzae, type b, were measured in the sera of 85 children aged 18 through 71 months. Bactericidal antibodies were present in only 21% of those over 60 months; RIA levels rose linearly with increasing age (P less than 0.005). Bactericidal antibodies were present in nine of 29 sera with RIA levels greater than or equal to 0.7 mug/ml and in only four of 56 sera with RIA levels less than 0.7 mug/ml (P less than 0.01). The discrepancies between the two tests probably reflect their measurement of different antibodies. Results of the RIA fit the clinical observation that H. influenzae meningitis becomes less frequent with age.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085776      PMCID: PMC274150     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.

Authors:  D H Smith; G Peter; D L Ingram; A L Harding; P Anderson
Journal:  Pediatrics       Date:  1973-11       Impact factor: 7.124

2.  Prevalence of bactericidal antibodies to Haemophilus influenzae, type b.

Authors:  C W Norden
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

3.  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

Authors:  J B Robbins; J C Parke; R Schneerson; J K Whisnant
Journal:  Pediatr Res       Date:  1973-03       Impact factor: 3.756

4.  Variable susceptibility of Hemophilus influenzae, type B strains to serum bactericidal activity.

Authors:  C W Norden
Journal:  Proc Soc Exp Biol Med       Date:  1972-01

5.  Increase in influenzal meningitis.

Authors:  R H Michaels
Journal:  N Engl J Med       Date:  1971-09-16       Impact factor: 91.245

6.  Type b haemophilus influenzae infections in adults.

Authors:  L Weinstein
Journal:  N Engl J Med       Date:  1970-01-22       Impact factor: 91.245

7.  Immunologic responses to Hemophilus influenzae meningitis.

Authors:  C W Norden; M Melish; J C Overall; J Baum
Journal:  J Pediatr       Date:  1972-02       Impact factor: 4.406

  7 in total
  7 in total

1.  Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody.

Authors:  T F Murphy; L C Bartos; P A Rice; M B Nelson; K C Dudas; M A Apicella
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  Immunology of the infant rat experimental model of Haemophilus influenzae type b meningitis.

Authors:  R L Myerowitz; C W Norden
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

3.  Bactericidal antibodies against noncapsular components of Haemophilus influenzae.

Authors:  T Dahlberg-Lagergård
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

4.  Role of nasopharyngeal colonization with and without bacteremia in the protection of infant rats against Haemophilus influenzae type b challenge.

Authors:  J R Gilsdorf; P Ferrieri
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

5.  Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens.

Authors:  P Anderson; A Flesher; S Shaw; A L Harding; D H Smith
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

6.  Incidence, predisposing factors and manifestations of invasive Haemophilus influenzae infections in adults.

Authors:  B Trollfors; B Claesson; T Lagergård; T Sandberg
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

7.  Quantitation of antibodies to Haemophilus influenzae type b in humans by enzyme-linked immunosorbent assay.

Authors:  T Dahlberg
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.